GW Pharmaceuticals Plc (GWPH)

175.05
5.55 3.07
NASDAQ : Health Technology
Prev Close 180.60
Open 179.90
Day Low/High 174.02 / 180.75
52 Wk Low/High 90.14 / 196.00
Volume 409.79K
Avg Volume 470.00K
Exchange NASDAQ
Shares Outstanding 30.72M
Market Cap 5.55B
EPS -10.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

The Trader Daily

My baseline expectation at Wednesday's open is downside extension.

GW Pharmaceuticals Plc Reports Second Quarter 2014 Financial Results And Operational Progress

GW Pharmaceuticals Plc Reports Second Quarter 2014 Financial Results And Operational Progress

Conference Call Today at 8:00 a.m. ET, 1:00 p.m. BST

GW Pharmaceuticals Appoints Dr. Kenneth Sommerville As VP, Clinical Science

GW Pharmaceuticals Appoints Dr. Kenneth Sommerville As VP, Clinical Science

Position Created to Support U.S. Medical Affairs and Regulatory Activities Related to Epilepsy Programs

Jim Cramer's Top Stock Picks: PNRA GWPH LOCK

Jim Cramer's Top Stock Picks: PNRA GWPH LOCK

Cramer has a taste for the improvements at Panera, is high on GW Pharmaceuticals and thinks LifeLock cheap stock is a steal.

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Today's move into the red caught investors by surprise because the economy seems to be improving. Here's what Cramer will be watching next week.

3 Stocks Spiking on Big Volume

3 Stocks Spiking on Big Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Jim Cramer's Stop Trading: The Go-To Medical Marijuana Stock

Jim Cramer's Stop Trading: The Go-To Medical Marijuana Stock

A new study says medical marijuana has benefits for patients with multiple sclerosis, and Cramer says the go-to stock in this area is GW Pharmaceuticals.

Autism Patients Could Be Helped with Cannabis

Autism Patients Could Be Helped with Cannabis

GW Pharmaceuticals hasn't pursued the autism patient population with its cannabis drugs, but impatient parents may not want to wait.

Why GW Pharmaceuticals (GWPH) Stock Is Up Today

Why GW Pharmaceuticals (GWPH) Stock Is Up Today

GW Pharmaceuticals (GWPH) is up after announcing that its Sativex drug received a fast track designation from the FDA.

'Mad Money' Lightning Round: United Rentals Is Really Good

'Mad Money' Lightning Round: United Rentals Is Really Good

Cramer prefers HollyFrontier to CVR Refining and says wait a bit on GW Pharmaceuticals.

Jim Cramer's 'Mad Money' Recap: Nerds Rule

Jim Cramer's 'Mad Money' Recap: Nerds Rule

Uncool companies left for dead last quarter are making a comeback, Cramer says.

Fitz Bits: Look Back Before Leaping

Fitz Bits: Look Back Before Leaping

Focus on the past can give a glimpse of what might happen.

Morgan Stanley Says GWPH Pot Stock Is Legit

Morgan Stanley Says GWPH Pot Stock Is Legit

Morgan Stanley has given GW Pharmaceuticals (GWPH) its vote of confidence, so will this increase confidence in marijuana stocks?

Why GW Pharmaceuticals (GWPH) Stock Is Soaring Today

Why GW Pharmaceuticals (GWPH) Stock Is Soaring Today

GW Pharmaceuticals (GWPH) shares are popping following coverage initiation at 'overweight' by analysts at Morgan Stanley (MS)

Jim Cramer's Stop Trading: GWPH

Jim Cramer's Stop Trading: GWPH

Cramer says GW Pharma is more than just a medical marijuana stock.

Cramer: 'Getting Rich Carefully' Rules Apply to Restaurants

Cramer: 'Getting Rich Carefully' Rules Apply to Restaurants

Jim Cramer reveals how the same rules he discusses in his latest book, 'Getting Rich Carefully,' apply to his newest investment, Mexican restaurant Bar San Miguel in Carroll Gardens, Brooklyn.

Marijuana Stocks Dry Up - Here's What the Charts Say

Marijuana Stocks Dry Up - Here's What the Charts Say

Marijuana stocks have recently shriveled up in value, causing many investors to wonder if the "green rush" is over.

Jim Cramer: Very Difficult to Crush This Market

Jim Cramer: Very Difficult to Crush This Market

Financials and tech, the most vital groups to the broader market, are far too robust.

Very Difficult to Crush This Market

Financials and tech, the most vital groups to the broader market, are far too robust.

CARA CEO: We Are Not Just a Medical Marijuana Stock

CARA CEO: We Are Not Just a Medical Marijuana Stock

Medical marijuana stocks have been all the rage and CARA has been lumped into that category, but the story is much deeper.

Canaccord Fumes Over Pot Deal

Canaccord Fumes Over Pot Deal

The Toronto-based wealth management and securities company helped aspiring pot grower Enertopia raise over a million dollars but, upon being informed by TheStreet that it had been credited in a regulatory filing, Canaccord wasn't feeling the vibes.

5 Biotech Stocks Spiking on Unusual Volume

5 Biotech Stocks Spiking on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.